F. O’Grady
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 2%
- Escherichia coli research studies
Papers in
-
- Antibiotic Resistance in Bacteria 31
- Co-authors
- David GreenwoodW. R. CattellA. VinceJ. C. B. FentonE. KnightA M DawsonN. J. PearsonL Sultan
- Journals
- The Lancet (12 papers)Journal of Antimicrobial Chemotherapy (9 papers)Journal of Medical Microbiology (8 papers)Journal of Clinical Pathology (7 papers)Antimicrobial Agents and Chemotherapy (7 papers)
- Partner nations
- United KingdomUnited StatesSouth Africa
In The Last Decade
F. O’Grady
138 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 163
- Molecular Medicine 554
- Endocrinology 294
- Pharmacology 501
- Urology 190
- Infectious Diseases 524
Countries citing papers authored by F. O’Grady
This map shows the geographic impact of F. O’Grady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. O’Grady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. O’Grady more than expected).
Fields of papers citing papers by F. O’Grady
This network shows the impact of papers produced by F. O’Grady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. O’Grady. The network helps show where F. O’Grady may publish in the future.
Co-authorship network
The 25 scholars most cited alongside F. O’Grady, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tuberculosis Disseminators1,2 | 2015 | 1 |
| 2 | Internally-developed electronic reporting system for medication errors. | 2010 | 4 |
| 3 | Antibiotic and chemotherapy : anti-infective agents and their use in therapy | 1997 | 47 |
| 4 | 1990 | 3 | |
| 5 | 1977 | 14 | |
| 6 | 1976 | 17 | |
| 7 | 1974 | 11 | |
| 8 | 1973 | 114 | |
| 9 | 1972 | 2 | |
| 10 | 1972 | 29 | |
| 11 | 1971 | 22 | |
| 12 | 1970 | 16 | |
| 13 | 1969 | 2 | |
| 14 | 1968 | 28 | |
| 15 | 1968 | 26 | |
| 16 | 1966 | 95 | |
| 17 | 1966 | 40 | |
| 18 | Nasal Carriage of Staphylococcus pyogenes. II. Bacterial Ecology of the Nose. | 1963 | 5 |
| 19 | 1963 | 2 | |
| 20 | Airborne infection : transmission and control | 1961 | 92 |
About F. O’Grady
F. O’Grady is a scholar working on Molecular Medicine, Endocrinology, Pharmacology, Epidemiology and Infectious Diseases, having authored 144 papers that have together received 2.7k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (34 papers), Antibiotic Resistance in Bacteria (31 papers), Urinary Tract Infections Management (30 papers), Bacterial Identification and Susceptibility Testing (8 papers), Tuberculosis Research and Epidemiology (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers), Pediatric Urology and Nephrology Studies (7 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (7 papers). The work is most often cited by research in Molecular Medicine (554 citations), Endocrinology (294 citations), Pharmacology (501 citations), Urology (190 citations) and Infectious Diseases (524 citations). F. O’Grady has collaborated with scholars based in United Kingdom, United States and South Africa. Frequent co-authors include David Greenwood, W. R. Cattell, A. Vince, J. C. B. Fenton, E. Knight, A M Dawson, N. J. Pearson, L Sultan, R. L. Riley and Richard L. Riley. Their work appears in journals such as The Lancet, Journal of Antimicrobial Chemotherapy, Journal of Medical Microbiology, Journal of Clinical Pathology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.